Рет қаралды 18,583
Xarelto and Eliquis compete for the same patients. These oral anticoagulants appear useful in reducing the risk of stroke associated with atrial fibrillation. They also minimize the risk for deep vein thrombosis and blood clots capable of traveling to the lungs as sometimes fatal pulmonary emboli. Unfortunately the once daily Xarelto might not provide round the clock protection. Serious concerns exist regarding its merits compared to other similar drugs.